BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10199584)

  • 21. Bis(maltolato)oxovanadium(IV) (BMOV) Attenuates Apoptosis in High Glucose-Treated Cardiac Cells and Diabetic Rat Hearts by Regulating the Unfolded Protein Responses (UPRs).
    Cong XQ; Piao MH; Li Y; Xie L; Liu Y
    Biol Trace Elem Res; 2016 Oct; 173(2):390-8. PubMed ID: 26983714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of vanadium on insulin and leptin in Zucker diabetic fatty rats.
    Wang J; Yuen VG; McNeill JH
    Mol Cell Biochem; 2001 Feb; 218(1-2):93-6. PubMed ID: 11330843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of BMOV [bis(maltolato)oxovanadium(IV)] on biochemical and morphological alterations characteristic for streptozotocin-diabetic rat liver Golgi complexes.
    Dabroś W; Dziga D; Kordowiak AM
    Pol J Pathol; 2002; 53(4):205-13. PubMed ID: 12597338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in iron metabolism and oxidative status in STZ-induced diabetic rats treated with bis(maltolato) oxovanadium (IV) as an antidiabetic agent.
    Sánchez-González C; López-Chaves C; Trenzado CE; Aranda P; López-Jurado M; Gómez-Aracena J; Montes-Bayón M; Sanz-Medel A; Llopis J
    ScientificWorldJournal; 2014; 2014():706074. PubMed ID: 24511298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calorimetric studies of the interaction between the insulin-enhancing drug candidate bis(maltolato)oxovanadium(IV) (BMOV) and human serum apo-transferrin.
    Bordbar AK; Creagh AL; Mohammadi F; Haynes CA; Orvig C
    J Inorg Biochem; 2009 Apr; 103(4):643-7. PubMed ID: 19056126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
    Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
    Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical and morphological alterations in rat liver Golgi complexes after treatment with bis(maltolato)oxovanadium(IV) [BMOV] or maltol alone.
    Dabroś W; Dziga D; Gryboś R; Kordowiak AM
    Pathol Res Pract; 2000; 196(8):561-8. PubMed ID: 10982019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of bis(maltolato)oxovanadium(IV) on activity of galactosyltransferase (GalT) and morphology of rat liver Golgi apparatus in control and streptozotocin diabetes.
    Dabroś W; Kordowiak AM; Dziga D; Gryboś R
    Pol J Pathol; 1998; 49(2):67-76. PubMed ID: 9798409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antecedent hyperglycemia, not hyperlipidemia, is associated with increased islet triacylglycerol content and decreased insulin gene mRNA level in Zucker diabetic fatty rats.
    Harmon JS; Gleason CE; Tanaka Y; Poitout V; Robertson RP
    Diabetes; 2001 Nov; 50(11):2481-6. PubMed ID: 11679425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased potency of vanadium using organic ligands.
    McNeill JH; Yuen VG; Dai S; Orvig C
    Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):175-80. PubMed ID: 8927036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of orexin gene expression by severe obesity in the rats: studies in Zucker fatty and zucker diabetic fatty rats and effects of rosiglitazone.
    Cai XJ; Lister CA; Buckingham RE; Pickavance L; Wilding J; Arch JR; Wilson S; Williams G
    Brain Res Mol Brain Res; 2000 Apr; 77(1):131-7. PubMed ID: 10814839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phlorizin treatment prevents the decrease in plasma insulin levels but not the progressive histopathological changes in the pancreatic islets during aging of Zucker diabetic fatty rats.
    Janssen SW; Martens GJ; Sweep CG; Span PN; Verhofstad AA; Hermus AR
    J Endocrinol Invest; 2003 Jun; 26(6):508-15. PubMed ID: 12952363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of insulin-like growth factor type 1 receptor and protein kinase Cdelta in bis(maltolato)oxovanadium(IV)-induced phosphorylation of protein kinase B in HepG2 cells.
    Mehdi MZ; Vardatsikos G; Pandey SK; Srivastava AK
    Biochemistry; 2006 Sep; 45(38):11605-15. PubMed ID: 16981720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absorption, transport and insulin-mimetic properties of bis(maltolato)oxovanadium (IV) in streptozotocin-induced hyperglycemic rats by integrated mass spectrometric techniques.
    Iglesias-González T; Sánchez-González C; Montes-Bayón M; Llopis-González J; Sanz-Medel A
    Anal Bioanal Chem; 2012 Jan; 402(1):277-85. PubMed ID: 21842199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats.
    Fujiwara T; Yoshioka S; Yoshioka T; Ushiyama I; Horikoshi H
    Diabetes; 1988 Nov; 37(11):1549-58. PubMed ID: 3053303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of anti-hyperglycemic effect amongst vanadium, molybdenum and other metal maltol complexes.
    Thompson KH; Chiles J; Yuen VG; Tse J; McNeill JH; Orvig C
    J Inorg Biochem; 2004 May; 98(5):683-90. PubMed ID: 15134913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Streptozotocin-induced alterations in rat liver Golgi complexes are ameliorated by BMOV [Bis(maltolato)oxovanadium(IV)] activity.
    Kordowiak AM; Dziga D; Dabroś W
    Horm Metab Res; 2004 Mar; 36(3):148-54. PubMed ID: 15057667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetic analysis and comparison of uptake, distribution, and excretion of 48V-labeled compounds in rats.
    Setyawati IA; Thompson KH; Yuen VG; Sun Y; Battell M; Lyster DM; Vo C; Ruth TJ; Zeisler S; McNeill JH; Orvig C
    J Appl Physiol (1985); 1998 Feb; 84(2):569-75. PubMed ID: 9475867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular mechanism of bis(maltolato)oxovanadium(IV)-induced insulin signaling in 3T3-L1 and IM9 cells: impact of dexamethasone.
    Bose S; Farah MA; Jung HC; Lee JH; Kim Y
    J Mol Endocrinol; 2007 Jun; 38(6):627-49. PubMed ID: 17556533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of three and eight weeks oral administration of bis(maltolato)oxovanadium(IV) on plasma homocysteine and cysteine levels in streptozotocin-induced diabetic rats.
    Wasan KM; Risovic V; Yuen VG; Hicke A; McNeill JH
    Exp Clin Cardiol; 2004; 9(2):125-9. PubMed ID: 19641699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.